When we announced the big iPSC breakthrough on November 20th, 2007 we have continued to see more and more promise AND progress with this ethical research. Remember, this is the research which takes and adult skin cell and then turns the stem cells back to an “embryonic” like state.

No eggs needed.
No embryos needed or destroyed.
Genetic match for the patient – you use their skin cells.

Check this out!

“PrimeGen, based in Irvine, California, says that its scientists have converted specialised adult human cells back to a seemingly embryonic state – using methods that are much less likely to trigger cancer than those deployed previously.

The company also claims to be able to produce reprogrammed cells faster and much more efficiently than other scientists.

Right now, the hottest area in stem cell biology is that of induced pluripotent stem cells, or iPS cells, which have the ability to develop into several different tissue types.”

Full article here.

Osiris just announced a stock increase too on a heart drug study with new encouraging data out.

“Biotechnology drug developer Osiris Therapeutics Inc. said Tuesday the Food and Drug Administration cleared the company to launch a midstage trial of Prochymal after a study showed the experimental drug improved heart function.Shares of Osiris rose 44 cents, or 3.7 percent, to $12.25 in afternoon trading.Interim results from an early-stage trial evaluating Prochymal for the treatment of heart attacks showed it was safe and “significantly” improved heart function after one year.”

Keep in mind, this is ethical adult stem cell research, which is in human clinical trials, helping patients NOW. Unlike *yawn* embryonic stem cell and cloning research which has produced zip to date.

Author Profile

Jennifer Lahl, CBC Founder
Jennifer Lahl, CBC Founder
Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.